147 related articles for article (PubMed ID: 16750429)
41. Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene.
Miltenberger-Miltenyi G; Janecke AR; Wanschitz JV; Timmerman V; Windpassinger C; Auer-Grumbach M; Löscher WN
Arch Neurol; 2007 Jul; 64(7):966-70. PubMed ID: 17620486
[TBL] [Abstract][Full Text] [Related]
42. Cloning of hOST-PTP: the only example of a protein-tyrosine-phosphatase the function of which has been lost between rodent and human.
Cousin W; Courseaux A; Ladoux A; Dani C; Peraldi P
Biochem Biophys Res Commun; 2004 Aug; 321(1):259-65. PubMed ID: 15358244
[TBL] [Abstract][Full Text] [Related]
43. An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model.
Seburn KL; Nangle LA; Cox GA; Schimmel P; Burgess RW
Neuron; 2006 Sep; 51(6):715-26. PubMed ID: 16982418
[TBL] [Abstract][Full Text] [Related]
44. Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase.
Kim SA; Vacratsis PO; Firestein R; Cleary ML; Dixon JE
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4492-7. PubMed ID: 12668758
[TBL] [Abstract][Full Text] [Related]
45. Hereditary motor and sensory neuropathy caused by a novel mutation in LITAF.
Gerding WM; Koetting J; Epplen JT; Neusch C
Neuromuscul Disord; 2009 Oct; 19(10):701-3. PubMed ID: 19541485
[TBL] [Abstract][Full Text] [Related]
46. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2.
Bolino A; Muglia M; Conforti FL; LeGuern E; Salih MA; Georgiou DM; Christodoulou K; Hausmanowa-Petrusewicz I; Mandich P; Schenone A; Gambardella A; Bono F; Quattrone A; Devoto M; Monaco AP
Nat Genet; 2000 May; 25(1):17-9. PubMed ID: 10802647
[TBL] [Abstract][Full Text] [Related]
47. Multiple disease-linked myotubularin mutations cause NFL assembly defects in cultured cells and disrupt myotubularin dimerization.
Goryunov D; Nightingale A; Bornfleth L; Leung C; Liem RK
J Neurochem; 2008 Mar; 104(6):1536-52. PubMed ID: 17973976
[TBL] [Abstract][Full Text] [Related]
48. SET binding factor 2 (SBF2) mutation causes CMT4B with juvenile onset glaucoma.
Hirano R; Takashima H; Umehara F; Arimura H; Michizono K; Okamoto Y; Nakagawa M; Boerkoel CF; Lupski JR; Osame M; Arimura K
Neurology; 2004 Aug; 63(3):577-80. PubMed ID: 15304601
[TBL] [Abstract][Full Text] [Related]
49. Charcot-Marie-Tooth disease: a clinico-genetic confrontation.
Barisic N; Claeys KG; Sirotković-Skerlev M; Löfgren A; Nelis E; De Jonghe P; Timmerman V
Ann Hum Genet; 2008 May; 72(Pt 3):416-41. PubMed ID: 18215208
[TBL] [Abstract][Full Text] [Related]
50. Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module.
Berger P; Schaffitzel C; Berger I; Ban N; Suter U
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12177-82. PubMed ID: 14530412
[TBL] [Abstract][Full Text] [Related]
51. Autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2): phenotype-genotype correlations in 13 Moroccan families.
Bouhouche A; Birouk N; Azzedine H; Benomar A; Durosier G; Ente D; Muriel MP; Ruberg M; Slassi I; Yahyaoui M; Dubourg O; Ouazzani R; LeGuern E
Brain; 2007 Apr; 130(Pt 4):1062-75. PubMed ID: 17347251
[TBL] [Abstract][Full Text] [Related]
52. [Non-fortuitous dynamin II mutation-related association: neutropenia and Charcot-Marie-Tooth disease].
Saint-Lézer A; Solé G; Ribeiro E; Latour P; Mercié P; Longy-Boursier M
Rev Neurol (Paris); 2012 Apr; 168(4):367-70. PubMed ID: 22385972
[TBL] [Abstract][Full Text] [Related]
53. Exclusion of the SCN2B gene as candidate for CMT4B.
Bolino A; Seri M; Caroli F; Eubanks J; Srinivasan J; Mandich P; Schenone A; Quattrone A; Romeo G; Catterall WA; Devoto M
Eur J Hum Genet; 1998; 6(6):629-34. PubMed ID: 9887383
[TBL] [Abstract][Full Text] [Related]
54. Is a novel I214M substitution in the NEFL gene a cause of Charcot-Marie-Tooth disease? Functional analysis using cell culture models.
Kabzińska D; Perez-Olle R; Goryunov D; Drac H; Ryniewicz B; Hausmanowa-Petrusewicz I; Kochański A; Liem RK
J Peripher Nerv Syst; 2006 Sep; 11(3):225-31. PubMed ID: 16930284
[TBL] [Abstract][Full Text] [Related]
55. NDRG1 interacts with APO A-I and A-II and is a functional candidate for the HDL-C QTL on 8q24.
Hunter M; Angelicheva D; Tournev I; Ingley E; Chan DC; Watts GF; Kremensky I; Kalaydjieva L
Biochem Biophys Res Commun; 2005 Jul; 332(4):982-92. PubMed ID: 15922294
[TBL] [Abstract][Full Text] [Related]
56. Clinical and molecular analysis of X-linked Charcot-Marie-Tooth disease type 1 in Spanish population.
Casasnovas C; Banchs I; Corral J; Martínez-Matos JA; Volpini V
Clin Genet; 2006 Dec; 70(6):516-23. PubMed ID: 17100997
[TBL] [Abstract][Full Text] [Related]
57. Molecular genetics of distal hereditary motor neuropathies.
Irobi J; De Jonghe P; Timmerman V
Hum Mol Genet; 2004 Oct; 13 Spec No 2():R195-202. PubMed ID: 15358725
[TBL] [Abstract][Full Text] [Related]
58. [A pedigree of Charcot-Marie-Tooth disease type 4F (Periaxin mutation)].
Shimohata M; Hirahara K; Igarashi S; Hara K; Kijima K; Onodera O; Tanaka K; Nishizawa M; Tsuji S; Hayasaka K
Rinsho Shinkeigaku; 2005 Mar; 45(3):221-5. PubMed ID: 15835292
[TBL] [Abstract][Full Text] [Related]
59. The coding region of TP53INP2, a gene expressed in the developing nervous system, is not altered in a family with autosomal recessive non-progressive infantile ataxia on chromosome 20q11-q13.
Bennetts JS; Rendtorff ND; Simpson F; Tranebjaerg L; Wicking C
Dev Dyn; 2007 Mar; 236(3):843-52. PubMed ID: 17238154
[TBL] [Abstract][Full Text] [Related]
60. Mechanisms of disease: inherited demyelinating neuropathies--from basic to clinical research.
Nave KA; Sereda MW; Ehrenreich H
Nat Clin Pract Neurol; 2007 Aug; 3(8):453-64. PubMed ID: 17671523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
